Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from medmix AG ( (CH:MEDX) ) is now available.
At the annual general meeting of medmix Ltd., shareholders approved all proposals from the Board of Directors, including the financial statements and a CHF 0.50 per share dividend. Key re-elections included Rob ten Hoedt as Chairman, and KPMG as auditor. These approvals reflect strong shareholder support and are expected to reinforce medmix’s strategic direction and operational stability.
More about medmix AG
medmix is a global leader in high-precision delivery devices, known for its innovation and technological advancement with over 900 active patents. The company operates 14 production sites worldwide and employs nearly 2,700 people, focusing on delivering quality and agility to its customers. Headquartered in Baar, Switzerland, medmix’s shares are traded on the SIX Swiss Exchange.
YTD Price Performance: 13.41%
Average Trading Volume: 61,511
Current Market Cap: CHF411.8M
For detailed information about MEDX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue